FABP4 was found to be one of the top 10 up-regulated genes in a transcriptome signature study performed in MASH patients [62], suggesting a relevant role not only for liver fat deposition, but also for MASH progression. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.